Merck’s Outnumber PAH campaign is being rolled out shortly after the pharma giant won regulatory approval for its PAH ...

(Clockwise from top left) Disney’s From Our Family to Yours, Wieden & Kennedy’s The Myth and Procter & Gamble’s The Name.

The Vantive separation is expected to take place in the second half of this year, whether through a sale to a private equity ...

One of the most defining features of psoriasis is how it presents on the physical body. Impacting an estimated 7.5 million ...

Biopharmaceutical company Gilead Sciences is bringing on Omnicom Group to manage PR for its HIV portfolio, according to a ...

Sand Capital closed its $555 million life sciences investment fund. Growth equity firm NewVale Capital announced its $167 ...

For many patients, seeing a nurse practitioner has become a routine part of primary care, in which these “NPs” often perform the same tasks that patients have relied on doctors for.

Making science accessible is a focal point of not only the Coffee Break Science series but also Moderna’s broader brand pivot ...

The Proteologix deal marks the second big pharma buy for J&J in 2024, following its acquisition of Amrbx Biopharma earlier ...

The UCLA protest, which gathered thousands in opposition to Israel’s ongoing bombing of Gaza, began in April and grew to a ...

Acelyrin announced that Shao-Lee Lin is stepping down as CEO. TikTok VP of global communications Hilary McQuaide announced ...

Consumers are still putting a high level of trust in their community pharmacies and are open to seeing pharmacists play a ...